Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million

Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million. Valinor Pharma Valinor Pharma Israel Algeria Bahrain Egypt Iran Iraq Jordan Kuwait Lebanon Libya Morocco Oman Qatar Saudi Arabia Syria Tunisia United Arab Emirates Yemen Angola Botswana Ethiopia Gambia Ghana Guinea-Bissau Kenya Lesotho Liberia Malawi Maldives Mozambique Namibia Nigeria Sierra Leone Somalia South Africa Swaziland Tanzania Uganda Zambia Zimbabwe Illinois

Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik® (naloxegol)View original content:https://www.prnewswire.co.uk/news-releases/valinor-pharma-announces-acquisition-by-grunenthal-with-a-total-deal-value-of-approximately-250-million-302202977.html